Evidence map›Paper›PMID 39591878›Full record

ArticleArtificial intelligence in medicine2025

Electronic Health Records-based identification of newly diagnosed Crohn's Disease cases.

Susanne Ibing, Julian Hugo, Florian Borchert, Linea Schmidt, Caroline Benson, Allison A Marshall, Colleen Chasteau, Ujunwa Korie, Diana Paguay, Jan Philipp Sachs and 4 more

Abstract read
In one paragraph

Article in Artificial intelligence in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Susanne IbingHasso Plattner Institute, Digital Engineering Faculty, University of Potsdam, Potsdam, Germany; Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, USA; Windreich Dept. of Artificial Intelligence & Human Health, Icahn School of Medicine at Mount Sinai, New York, USA.
Julian HugoHasso Plattner Institute, Digital Engineering Faculty, University of Potsdam, Potsdam, Germany; Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, USA.
Florian BorchertHasso Plattner Institute, Digital Engineering Faculty, University of Potsdam, Potsdam, Germany; Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, USA.
Linea SchmidtHasso Plattner Institute, Digital Engineering Faculty, University of Potsdam, Potsdam, Germany; Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, USA; Windreich Dept. of Artificial Intelligence & Human Health, Icahn School of Medicine at Mount Sinai, New York, USA.
Caroline BensonThe Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, USA.
Allison A MarshallDepartment of Medicine, Mount Sinai Health System, New York, USA.
Colleen ChasteauDepartment of Pathology, Molecular, and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.
Ujunwa KorieDepartment of Pathology, Molecular, and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.
Diana PaguayDepartment of Pathology, Molecular, and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.
Jan Philipp SachsHasso Plattner Institute, Digital Engineering Faculty, University of Potsdam, Potsdam, Germany; Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, USA; Windreich Dept. of Artificial Intelligence & Human Health, Icahn School of Medicine at Mount Sinai, New York, USA.
Bernhard Y RenardHasso Plattner Institute, Digital Engineering Faculty, University of Potsdam, Potsdam, Germany; Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, USA; Windreich Dept. of Artificial Intelligence & Human Health, Icahn School of Medicine at Mount Sinai, New York, USA.
Judy H ChoDepartment of Pathology, Molecular, and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.
Erwin P BöttingerHasso Plattner Institute, Digital Engineering Faculty, University of Potsdam, Potsdam, Germany; Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, USA; Windreich Dept. of Artificial Intelligence & Human Health, Icahn School of Medicine at Mount Sinai, New York, USA.
Ryan C UngaroThe Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, USA. Electronic address: ryan.ungaro@mssm.edu.

Funding

Conduits: Mount Sinai Health System Translational Science HubUL1TR004419 · NCATS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Rosalind J Wright · 2022 to 2026
$46.4M
Precision IBD via genetics and genomics: integrating International and multi-omic datasets, expanding studies in diverse populations, and defining mechanisms of unmet clinical needs in IBDU24DK062429 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ling-shiang Chuang, Ron Do · 2017 to 2026
$13.9M
Yale University Inflammatory Bowel Disease Genetics Research CenterU01DK062422 · NIDDK · YALE UNIVERSITY · PI Ling-shiang Chuang · 2002 to 2026
$10.8M
Intestinal single cell analyses and population differences in innate immunity in Crohn's disease drive treatment response and clinical heterogeneity: towards Precision IBDR01DK123758 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHO, JUDY H. · 2020 to 2023
$2.9M
COVID and Translational Science supercomputer (CATS)S10OD030463 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2021 to 2021
$2.0M
Assessing Predictors of Response to Anti-Tumor Necrosis Alpha Therapy in Early Crohns DiseaseK23DK111995 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI UNGARO, RYAN · 2019 to 2023
$948k
Blood Protein Markers of Biologic Treatment Response in Crohn's DiseaseR03DK132440 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI UNGARO, RYAN · 2023 to 2024
$248k
NCATS NIH HHS UL1 TR004419NIDDK NIH HHS K23 DK111995NIDDK NIH HHS R01 DK123758NIDDK NIH HHS R03 DK132440NIDDK NIH HHS U01 DK062422NIDDK NIH HHS U24 DK062429NIH HHS S10 OD030463
6 · The paper itself

Abstract

backgroundEarly diagnosis and treatment of Crohn's Disease are associated with decreased risk of surgery and complications. However, diagnostic delay is frequently seen in clinical practice. To better understand Crohn's Disease risk factors and disease indicators, we identified, described, and predicted incident Crohn's Disease patients based on the Electronic Health Record data of the Mount Sinai Health System.

methodsWe developed two phenotyping algorithms based on structured Electronic Health Record data (i.e., coded diagnosis, medication prescription, and healthcare utilization), and a more simple and advanced approach of information extraction from clinical notes, including data between 2011 and 2023. We conducted an ablation study for the classification task using different models, prediction time points, data inputs, text encoding methods, and case-control matching variables.

resultsWe identified 247 incident Crohn's Disease cases and 1221 matched controls and validated our cohorts through manual chart review. A second control cohort (n = 1235) was created without matching on race. Gastrointestinal symptoms were significantly overrepresented in cases at least 180 days before the first coded Crohn's Disease diagnosis. Adding text-based features to the clinical prediction models increased their overall performances. However, adding race as a matching variable had more effects on the model performance than the choice of modeling algorithm or input data, with an area under the receiver operating characteristic difference of 0.09 between the best-performing models.

conclusionWe demonstrate the feasibility of identifying newly diagnosed Crohn's Disease patients within a United States health system using Electronic Health Records. For the predictive modeling task, cases and controls were distinguished only with modest performance, even though various state-of-the-art methods were applied based on features from structured and unstructured data. Our findings suggest the benefit of adding information from clinical notes in a supervised or unsupervised manner for cohort creation and predictive modeling.

Indexed as

AlgorithmsCrohn DiseaseElectronic Health RecordsAdultCase-Control StudiesFemaleHumansMaleMiddle AgedRisk FactorsYoung AdultClinical predictive modelingCrohn’s diseaseDiagnostic delayElectronic health records

Identifiers

PMID39591878
PMCPMC12067941

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.